Literature DB >> 29408722

Is LSD toxic?

David E Nichols1, Charles S Grob2.   

Abstract

LSD (lysergic acid diethylamide) was discovered almost 75 years ago, and has been the object of episodic controversy since then. While initially explored as an adjunctive psychiatric treatment, its recreational use by the general public has persisted and on occasion has been associated with adverse outcomes, particularly when the drug is taken under suboptimal conditions. LSD's potential to cause psychological disturbance (bad trips) has been long understood, and has rarely been associated with accidental deaths and suicide. From a physiological perspective, however, LSD is known to be non-toxic and medically safe when taken at standard dosages (50-200μg). The scientific literature, along with recent media reports, have unfortunately implicated "LSD toxicity" in five cases of sudden death. On close examination, however, two of these fatalities were associated with ingestion of massive overdoses, two were evidently in individuals with psychological agitation after taking standard doses of LSD who were then placed in maximal physical restraint positions (hogtied) by police, following which they suffered fatal cardiovascular collapse, and one case of extreme hyperthermia leading to death that was likely caused by a drug substituted for LSD with strong effects on central nervous system temperature regulation (e.g. 25i-NBOMe). Given the renewed interest in the therapeutic potential of LSD and other psychedelic drugs, it is important that an accurate understanding be established of the true causes of such fatalities that had been erroneously attributed to LSD toxicity, including massive overdoses, excessive physical restraints, and psychoactive drugs other than LSD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Death; Hog-tying; LSD; Maximal restraint; Positional asphyxiation; Toxicity

Mesh:

Substances:

Year:  2018        PMID: 29408722     DOI: 10.1016/j.forsciint.2018.01.006

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  10 in total

Review 1.  Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.

Authors:  David Bender; David J Hellerstein
Journal:  Psychopharmacology (Berl)       Date:  2022-01-13       Impact factor: 4.530

Review 2.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

3.  LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice.

Authors:  Kenneth Alper; Bin Dong; Relish Shah; Henry Sershen; K Yaragudri Vinod
Journal:  Front Pharmacol       Date:  2018-08-31       Impact factor: 5.810

4.  Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.

Authors:  Monika Herian; Adam Wojtas; Marzena Maćkowiak; Agnieszka Wawrzczak-Bargiela; Anna Solarz; Agnieszka Bysiek; Katarzyna Madej; Krystyna Gołembiowska
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

5.  Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD).

Authors:  Emma I Kopra; Jason A Ferris; James J Rucker; Benjamin McClure; Allan H Young; Caroline S Copeland; Adam R Winstock
Journal:  J Psychopharmacol       Date:  2022-06-07       Impact factor: 4.562

Review 6.  Serotonin toxicity of serotonergic psychedelics.

Authors:  Benjamin Malcolm; Kelan Thomas
Journal:  Psychopharmacology (Berl)       Date:  2021-07-12       Impact factor: 4.530

Review 7.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

8.  Self-inflicted neck wounds under influence of lysergic acid diethylamide: A case report and literature review.

Authors:  Brendan Le Daré; Thomas Gicquel; Alain Baert; Isabelle Morel; Renaud Bouvet
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

9.  A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

Authors:  Johannes G Ramaekers; Nadia Hutten; Natasha L Mason; Patrick Dolder; Eef L Theunissen; Friederike Holze; Matthias E Liechti; Amanda Feilding; Kim Pc Kuypers
Journal:  J Psychopharmacol       Date:  2020-08-25       Impact factor: 4.153

Review 10.  Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.

Authors:  Anne K Schlag; Jacob Aday; Iram Salam; Jo C Neill; David J Nutt
Journal:  J Psychopharmacol       Date:  2022-02-02       Impact factor: 4.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.